Related Experiment Video
Updated: Apr 1, 2026

An Iodide-Yellow Fluorescent Protein-Gap Junction-Intercellular Communication Assay
Published on: February 1, 2019
Models and methods for in vitro testing of hepatic gap junctional communication
Michaël Maes1, Sara Crespo Yanguas1, Joost Willebrords1
1Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium.
Abstract:
Inherent to their pivotal roles in controlling all aspects of the liver cell life cycle, hepatocellular gap junctions are frequently disrupted upon impairment of the homeostatic balance, as occurs during liver toxicity. Hepatic gap junctions, which are mainly built up by connexin32, are specifically targeted by tumor promoters and epigenetic carcinogens. This renders inhibition of gap junction functionality a suitable indicator for the in vitro detection of nongenotoxic hepatocarcinogenicity. The establishment of a reliable liver gap junction inhibition assay for routine in vitro testing purposes requires a cellular system in which gap junctions are expressed at an in vivo-like level as well as an appropriate technique to probe gap junction activity. Both these models and methods are discussed in the current paper, thereby focusing on connexin32-based gap junctions.
Insights
Liver cell gap junctions, primarily connexin32, are disrupted by toxins. Their inhibition indicates non-genotoxic hepatocarcinogenicity, making it a key biomarker for liver toxicity testing.
Area of Science:
- Hepatocellular biology and toxicology
- Cellular communication and gap junctions
Background:
- Hepatocellular gap junctions, mainly connexin32, regulate liver cell life cycles.
- These junctions are disrupted by impaired homeostatic balance, such as during liver toxicity.
- Tumor promoters and epigenetic carcinogens specifically target hepatic gap junctions.
Purpose of the Study:
- To establish connexin32-based gap junction inhibition assays for routine in vitro testing.
- To identify reliable cellular systems and techniques for probing gap junction activity in liver toxicity assessment.
Main Methods:
- Discussion of cellular models expressing in vivo-like levels of gap junctions.
- Review of appropriate techniques for assessing gap junction activity and inhibition.
- Focus on connexin32-based gap junctions for assay development.
Main Results:
- Inhibition of gap junction functionality serves as a reliable indicator for detecting non-genotoxic hepatocarcinogenicity.
- The study discusses models and methods crucial for developing robust in vitro liver toxicity assays.
Conclusions:
- Connexin32-based gap junction inhibition assays are suitable for in vitro detection of non-genotoxic hepatocarcinogenicity.
- Development of reliable assays requires specific cellular systems and techniques to probe gap junction activity.
More Related Videos
05:27Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products
Published on: December 25, 2016
11:02A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide
Published on: October 18, 2014
Related Concept Videos
Gap Junctions
Gap Junctions
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...